{
  "description": null,
  "compose": {
    "include": [ {
      "valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1168" ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113883.3.464.1003.196.12.1288.json",
  "package_name": "us.nlm.vsac",
  "date": "2017-05-04T01:00:13-04:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "2",
    "lastUpdated": "2017-05-04T01:00:13.000-04:00"
  },
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "name": "ErgoloidMesylates",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 1,
    "contains": [ {
      "code": "318179",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "ergoloid mesylates, USP 1 MG Oral Tablet",
      "version": "10022023"
    } ],
    "timestamp": "2023-11-15T07:10:08-05:00",
    "identifier": "urn:uuid:f1296528-c3ec-4abd-91a9-ca458f46ad5f"
  },
  "title": "Ergoloid Mesylates",
  "package_version": "0.15.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "NCQA PHEMUR Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2022-12-15"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2017-05-04"
  } ],
  "status": "active",
  "id": "f7c0a673-75d7-4c0a-83d9-908369c7eedf",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1288",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1288",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20170504"
}